Sign inJoin waitlistJoin the waitlist

Bradley Blaser

Associate Professor · Ohio State University Hospital

Credentials: · · · · ·

History

Ohio State University Hospital
Present

Medical Oncology
2011–2013
Internal Medicine
Mass General Brigham
2008–2011
Ohio State University College of Medicine
2004–2008

Research

The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR/ABL-regulated SET protein
Cancer Cell · 2005 · 398 citations
Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells
Blood · 2009 · 329 citations
FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia
Journal of Clinical Investigation · 2007 · 301 citations

MC
Michael Caligiuri
19 papers
James Blachly
7 papers
Michael Becknell
7 papers · 1 as a resident
Robert Baiocchi
6 papers · 2 as a fellow
Aharon Freud
4 papers · 1 as a resident
Guido Marcucci
4 papers
JB
John Byrd
4 papers
Lapo Alinari
4 papers
Leonard Zon
4 papers
Sameek Roychowdhury
4 papers · 1 as a resident
William Carson
4 papers
Anne Noonan
3 papers

Grants

Epigenetic Control of Vascular Niche Capacity to Support Hematopoiesis.
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $1.5M · Ohio State University
2021–2027
Targeting Autocrine Hepatocyte Growth Factor (HGF) Production as a Therapeutic Modality in Acute Myeloid Leukemia (AML)
National Cancer Institute · R21
PI · $415.2K · University of California, San Francisco
2022–2025
Regulation of Zebrafish Hematopoiesis by the Sinusoidal Endothelial Cell Niche
National Institute of Diabetes and Digestive and Kidney Diseases · K08
Contact PI · $759.1K · Ohio State University
2017–2022